FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer
Advanced Urologic Cancer Consensus Conference (AUC3) 2025 - ACS Journals
Gevorg Tamamyan: We Can Do More…
Clifford Hudis Encourages ASCO Members to Participate in the 2025 Survey as It Nears Close
Richard R. Barakat: A Powerful Northwell Cancer Institute–START Collaboration Bringing Early-Phase Trials to Patients
Arnaud Lallouette: Energy, Ambition, and Teamwork Across the Servier Performance Summit 2025 Tour
Senator Ron Johnson Thanks Secretary Kennedy for Advocacy in Early Sscreening for Rare Diseases
Meet the 2025 BCRF-AACR Career Development Award Recipients - AACR
The 2026 Multidisciplinary Head and Neck Cancers Symposium is a two-and-a-half-day event scheduled for February 19-21, 2026. Organized by ASTRO (American Society for Radiation Oncology) and co-sponsored by other key medical societies, the symposium will be held both in-person in Palm Desert, California, and as a live virtual meeting online. The central theme for the […]
The Advocates Webinar: Modernizing Oncology Endpoints, hosted virtually by Friends of Cancer Research (Friends), is a free, advocates-focused session scheduled for Thursday, February 19, 2026, from 12:00 PM to 1:00 […]
The APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit is a two-day continuing medical education conference organized by Horizon CME, scheduled for February 20th – 21st, 2026, at the […]
The Highlights in GI Oncology conference, hosted by Horizon CME, is a two-day educational program providing the latest science and practice-changing advances from the world's premier GI oncology event, the […]
The Oncology APP Leadership Forum 2026 is the 3rd annual two-day conference designed for current and aspiring Advanced Practice Provider (APP) leaders, managers, administrators, and directors in oncology. Scheduled for […]
The 16th World ADC London, set to convene at ExCeL London from February 23–26, 2026, stands as Europe’s premier conference dedicated to Antibody-Drug Conjugates (ADCs). The central focus of the 2026 […]
The Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond is the European Association for Cancer Research’s (EACR) inaugural virtual conference on this topic, scheduled for February 24–25, […]
The 9th CAR-TCR Summit Europe 2026 is the essential, industry-dedicated forum for next-generation cell therapy, scheduled from February 24–26, 2026, in London, UK, at the Park Plaza Victoria hotel. Organized […]
The Colorectal Liver Metastasis Consensus Conference, based on the Danish-Zurich model, is a three-day in-person conference dedicated to advancing care, research, and building consensus for the treatment of colorectal liver […]
The ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the complex management of gastroesophageal cancers using real-world clinical cases. The webinar will be broadcast live virtually on February 25, 2026, at 18:30 CET. The discussion […]
The 2026 ASCO Genitourinary (GU) Cancers Symposium is scheduled to take place from February 26 to 28, 2026, at Moscone West in San Francisco, California. This premier event, hosted by the American Society of Clinical Oncology (ASCO), will focus on the latest advancements in the prevention, diagnosis, and treatment of genitourinary cancers, including prostate, bladder, […]
The "2026 Translating Evidence to Action: Elevating Cancer Care" is an annual continuing medical education (CME) forum organized by Memorial Sloan Kettering Cancer Center (MSK), scheduled as a live virtual […]